BackFresenius Medical Care AG Overview

Fresenius Medical Care AG Other Current Assets

Latest other current assets for FMS: $440M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$442.88M
↓ 38.34% YoYΔ $-275.40M vs prior year quarter

Peer average / median

Loading

Fresenius Medical Care AG Other Current Assets History

Loading

Fresenius Medical Care AG vs. peers: Other Current Assets Comparison

Loading

Fresenius Medical Care AG Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Fresenius Medical Care AG (FMS) FAQ

Fresenius Medical Care AG's other current assets stands at $440M as of June 2026. That compares with $720M in the prior-year period — down 38.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Fresenius Medical Care AG reported $440M in other current assets versus $720M a year earlier — a 38.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $720M in the prior-year period — down 38.3% year over year. Sustained growth in other current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Fresenius Medical Care AG's other current assets evolved across reporting periods, while the comparison chart places FMS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other current assets is commonly used to spot outliers. Fresenius Medical Care AG's reading of $440M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.